Skip to content

Released Aug 4, 2022, after the close

10-Q filed Aug 5, 2022, 36 days after period end · 0001636422-22-000041

Q2 2022 · 10-Q
Revenue$70.63M+18.5% vs Q2 2021+3.7% vs Q1 2022
Net Income-$33.43MN/M vs Q2 2021N/M vs Q1 2022
EPS Diluted-$0.62N/M vs Q2 2021N/M vs Q1 2022
Operating Income-$33,192,000N/M
Operating Cash Flowderived-$9,576,000N/M
Free Cash Flowderived-$9,778,000N/M
Margins · derived
Operating margin-47.0%+7.2 pt vs Q2 2021
Net margin-47.3%+12.8 pt vs Q2 2021

What the release said

The release

Same quarter

MetricQ2 2022Q2 2021Q2 2020Q2 2019
Revenue$70.63M$59.63M$43.26M$36.80M
Net Income-$33.43M-$35.83M-$27.18M-$10.69M
EPS Diluted-$0.62-$0.80-$0.71-$21.98

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Health Catalyst, Inc. · CIK 1636422 · Engraved from SEC EDGAR